- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Intercept Pharmaceuticals Inc
+ Add to WatchlistICPT:US
34.1600 USD 1.2600 3.83%As of 14:54:25 ET on 05/23/2013.
Company Profile for Intercept Pharmaceuticals Inc (ICPT)
Intercept Pharmaceuticals Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
Contact Information
Intercept Pharmaceuticals Inc
18 Desbrosses Street
New York, NY 10013
United States
Key Executives for Intercept Pharmaceuticals Inc (ICPT)
| Mark PruzanskiPresident/CEO/Co-Founder | Barbara DuncanCFO/Treasurer/Secretary |
| Luciano AdoriniChief Scientific Officer | Daniel P ReganChief Commercial Officer |
| David ShapiroExec VP:Dev/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page